Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;34(7):1954-1956.
doi: 10.1038/s41375-020-0870-5. Epub 2020 May 19.

CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report

Tycho Baumann  1 , Julio Delgado  1 , Emili Montserrat  2
Affiliations

CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report

Tycho Baumann et al. Leukemia. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Comment in

Similar articles

  • COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
    Scarfò L, Chatzikonstantinou T, Rigolin GM, Quaresmini G, Motta M, Vitale C, Garcia-Marco JA, Hernández-Rivas JÁ, Mirás F, Baile M, Marquet J, Niemann CU, Reda G, Munir T, Gimeno E, Marchetti M, Quaglia FM, Varettoni M, Delgado J, Iyengar S, Janssens A, Marasca R, Ferrari A, Cuéllar-García C, Itchaki G, Špaček M, De Paoli L, Laurenti L, Levin MD, Lista E, Mauro FR, Šimkovič M, Van Der Spek E, Vandenberghe E, Trentin L, Wasik-Szczepanek E, Ruchlemer R, Bron D, De Paolis MR, Del Poeta G, Farina L, Foglietta M, Gentile M, Herishanu Y, Herold T, Jaksic O, Kater AP, Kersting S, Malerba L, Orsucci L, Popov VM, Sportoletti P, Yassin M, Pocali B, Barna G, Chiarenza A, Dos Santos G, Nikitin E, Andres M, Dimou M, Doubek M, Enrico A, Hakobyan Y, Kalashnikova O, Ortiz Pareja M, Papaioannou M, Rossi D, Shah N, Shrestha A, Stanca O, Stavroyianni N, Strugov V, Tam C, Zdrenghea M, Coscia M, Stamatopoulos K, Rossi G, Rambaldi A, Montserrat E, Foà R, Cuneo A, Ghia P. Scarfò L, et al. Leukemia. 2020 Sep;34(9):2354-2363. doi: 10.1038/s41375-020-0959-x. Epub 2020 Jul 9. Leukemia. 2020. PMID: 32647324 Free PMC article.
  • Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
    Thibaud S, Tremblay D, Bhalla S, Zimmerman B, Sigel K, Gabrilove J. Thibaud S, et al. Br J Haematol. 2020 Jul;190(2):e73-e76. doi: 10.1111/bjh.16863. Epub 2020 Jun 4. Br J Haematol. 2020. PMID: 32433778 Free PMC article. No abstract available.
  • The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.
    Treon SP, Castillo JJ, Skarbnik AP, Soumerai JD, Ghobrial IM, Guerrera ML, Meid K, Yang G. Treon SP, et al. Blood. 2020 May 21;135(21):1912-1915. doi: 10.1182/blood.2020006288. Blood. 2020. PMID: 32302379 Free PMC article. No abstract available.
  • The microbial coinfection in COVID-19.
    Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, Hu T, Li J, Zhou X, Ren B. Chen X, et al. Appl Microbiol Biotechnol. 2020 Sep;104(18):7777-7785. doi: 10.1007/s00253-020-10814-6. Epub 2020 Aug 11. Appl Microbiol Biotechnol. 2020. PMID: 32780290 Free PMC article. Review.
  • Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
    Brufsky A. Brufsky A. J Med Virol. 2020 Jul;92(7):770-775. doi: 10.1002/jmv.25887. Epub 2020 Apr 27. J Med Virol. 2020. PMID: 32293710 Free PMC article. Review.
See all similar articles

Cited by

  • Weathering the storm: COVID-19 infection in patients with hematological malignancies.
    Wang LQ, Tan Su Yin E, Wei GQ, Hu YX, Nagler A, Huang H. Wang LQ, et al. J Zhejiang Univ Sci B. 2020 Dec.;21(12):921-939. doi: 10.1631/jzus.B2000423. J Zhejiang Univ Sci B. 2020. PMID: 33843158 Free PMC article. Review.
  • Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges.
    Roosta Y, Behzadi F, Askari E, Raeisi M, Danandeh Mehr A, Nouri-Vaskeh M. Roosta Y, et al. Leuk Res Rep. 2021;15:100239. doi: 10.1016/j.lrr.2021.100239. Epub 2021 Mar 16. Leuk Res Rep. 2021. PMID: 33747763 Free PMC article. Review.
  • Immunologic characterization of COVID-19 patients with hematological cancer.
    Maia C, Martín-Sánchez E, Garcés JJ, De Cerio AL, Inogés S, Landecho MF, Gil-Alzugaray B, Perez C, Botta C, Zabaleta A, Alegre F, Rincón C, Blanco L, Sarvide S, Vilas-Zornoza A, Alignani D, Moreno C, Paiva A, Martinho A, Alves R, Colado E, Quirós C, Olid M, Blanco A, Argemi J, Paiva B, Yuste JR. Maia C, et al. Haematologica. 2020 Dec 17;106(5):1457-1460. doi: 10.3324/haematol.2020.269878. Haematologica. 2020. PMID: 33327714 Free PMC article.
  • COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
    Scarfò L, Chatzikonstantinou T, Rigolin GM, Quaresmini G, Motta M, Vitale C, Garcia-Marco JA, Hernández-Rivas JÁ, Mirás F, Baile M, Marquet J, Niemann CU, Reda G, Munir T, Gimeno E, Marchetti M, Quaglia FM, Varettoni M, Delgado J, Iyengar S, Janssens A, Marasca R, Ferrari A, Cuéllar-García C, Itchaki G, Špaček M, De Paoli L, Laurenti L, Levin MD, Lista E, Mauro FR, Šimkovič M, Van Der Spek E, Vandenberghe E, Trentin L, Wasik-Szczepanek E, Ruchlemer R, Bron D, De Paolis MR, Del Poeta G, Farina L, Foglietta M, Gentile M, Herishanu Y, Herold T, Jaksic O, Kater AP, Kersting S, Malerba L, Orsucci L, Popov VM, Sportoletti P, Yassin M, Pocali B, Barna G, Chiarenza A, Dos Santos G, Nikitin E, Andres M, Dimou M, Doubek M, Enrico A, Hakobyan Y, Kalashnikova O, Ortiz Pareja M, Papaioannou M, Rossi D, Shah N, Shrestha A, Stanca O, Stavroyianni N, Strugov V, Tam C, Zdrenghea M, Coscia M, Stamatopoulos K, Rossi G, Rambaldi A, Montserrat E, Foà R, Cuneo A, Ghia P. Scarfò L, et al. Leukemia. 2020 Sep;34(9):2354-2363. doi: 10.1038/s41375-020-0959-x. Epub 2020 Jul 9. Leukemia. 2020. PMID: 32647324 Free PMC article.
  • Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.
    Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, Barbian K, Judson SD, Fischer ER, Martens C, Bowden TA, de Wit E, Riedo FX, Munster VJ. Avanzato VA, et al. Cell. 2020 Dec 23;183(7):1901-1912.e9. doi: 10.1016/j.cell.2020.10.049. Epub 2020 Nov 4. Cell. 2020. PMID: 33248470 Free PMC article.
See all "Cited by" articles

References

    1. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 5 May 2020.
    1. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7. doi: 10.1016/S1470-2045(20)30096-6. - DOI - PMC - PubMed
    1. https://seer.cancer.gov/statfacts/html/clyl.html. Accessed 5 May 2020.
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Oncol. 2020;395:1054–62. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VM, Tzouanas CN, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020. 10.1016/j.cell.2020.04.035. - PMC - PubMed

MeSH terms